ARK Genomic Revolution ETF
0.75%
1.7B
1,730M USDHigh
135
Physical
Distributing
USD
US
ARK Genomic Revolution Index
ARK
2014-10-31 (11 years)
With 1.7B in assets, this is a large fund — good liquidity and tight spreads.
A TER of 0.75% is above the market average (~0.35%) — justified if the strategy is specialized.
Launched in 2014-10-31, this fund has 11 years of history — long and reliable track record.
High risk — suited for long-term investors comfortable with volatility.
Simulated from available data points. Past returns do not guarantee future results.
| Period | Ann. Return | Cumulative |
|---|---|---|
| 1 Month (est.) | — | +4.3% |
| 3 Months (est.) | — | +13.3% |
| 6 Months (est.) | — | +28.4% |
| YTD (est.) | — | +23.2% |
| 1 Year | +64.9% | +64.9% |
| 3 Years | +4.3% | +13.4% |
| 5 Years | -15.0% | -55.7% |
| Since inception (11y) | +18.1% | +521.4% |
135
62.3%
38.6%
38.8%
40.5%
1.39
0.22
-0.29
0.75%
-79.4%
-0.29
40.5%
Select your country in the menu to see available brokers and wrappers.
The ARK Genomic Revolution ETF tracks the ARK Genomic Revolution Index index. It is managed by ARK using physical replication and follows a distributing distribution policy. The fund is denominated in USD and domiciled in US. It has a total expense ratio (TER) of 0.75%.
This ranking is for informational purposes only and does not constitute a recommendation to buy or sell any security. Displayed performance is simulated.